Suppr超能文献

拓扑异构酶II作为新型抗生素的靶点:一项计算机模拟研究

Topoisomerase II as a target for repurposed antibiotics in : an in silico study.

作者信息

Jadhav Ashwini Khanderao, Karuppayil Sankunny Mohan

机构信息

Department of Stem Cell and Regenerative Medicine, Centre for Interdisciplinary Research, DY Patil Education Society (Deemed to be University), (NAAC Re Accredited with 'A' Grade), Kolhapur, Maharashtra 416006 India.

出版信息

In Silico Pharmacol. 2021 Mar 26;9(1):24. doi: 10.1007/s40203-021-00082-1. eCollection 2021.

Abstract

Fluoroquinolines, the widely used antibacterial antibiotics, have been shown to interact with human DNA topoisomerases supporting their use as repurposed cancer drugs in humans. In this communication molecular docking of eleven Fluoroquinolines against predicted structure of Topoisomerase II is reported for the first time. topoisomerase II structure prediction was done by using homology modeling tool. Ligand preparation and molecular docking with topoisomerase II were done by using Autodock tool. These antibiotics formed hydrogen bond with good binding affinity at ARG 841, GLN803, ALA840 amino acid residues in the active site of Topoisomerase II. We hypothesize that DNA toposiomerases may be the targets of Fluroquinoline group of antibiotics in causing inhibition of growth.

摘要

氟喹诺酮类药物是广泛使用的抗菌抗生素,已被证明可与人类DNA拓扑异构酶相互作用,这支持了它们作为人类癌症药物重新利用的用途。在本通讯中,首次报道了11种氟喹诺酮类药物针对拓扑异构酶II预测结构的分子对接。拓扑异构酶II结构预测通过使用同源建模工具完成。配体制备和与拓扑异构酶II的分子对接通过使用Autodock工具完成。这些抗生素在拓扑异构酶II活性位点的ARG 841、GLN803、ALA840氨基酸残基处形成具有良好结合亲和力的氢键。我们假设DNA拓扑异构酶可能是氟喹诺酮类抗生素导致生长抑制的靶点。

相似文献

本文引用的文献

6
Mechanism of quinolone action and resistance.喹诺酮类药物作用机制与耐药性
Biochemistry. 2014 Mar 18;53(10):1565-74. doi: 10.1021/bi5000564. Epub 2014 Mar 7.
9
Drugging topoisomerases: lessons and challenges.靶向拓扑异构酶药物:经验与挑战。
ACS Chem Biol. 2013 Jan 18;8(1):82-95. doi: 10.1021/cb300648v. Epub 2013 Jan 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验